Catalyst Wire Dossier Catalyst Wire Dossier

HEC96719

· Sunshine Lake Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEC96719, covering 2024-02-21 to 2024-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis [Phase 2]

See pricing